News

Popular GLP-1 and GIP medications, such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) are changing the way obesity and type 2 diabetes are viewed and treated.

Technology created at The University of Queensland, in collaboration with Newcastle researchers, could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions.

The University of Newcastle is proud to congratulate all recipients who have been recognised in the 2026 Australia Day Honours, particularly those who make up the vibrant and growing University community.

Respiratory researchers are set to investigate a surprising driver of poor lung health: the body’s metabolism.

More children across Australia and New Zealand diagnosed with high-grade brain cancers will soon have the opportunity to take part in a world-leading international clinical trial, with the TarGeT trial set to open locally in 2026. The TarGeT trial is an innovative umbrella trial, a clinical trial design that tests multiple targeted treatments for a single di

Three University of Newcastle research teams have been awarded more than $3.8 million in National Health and Medical Research Council (NHMRC) Ideas Grants, designed to support innovative research projects which address a specific question.

Their backgrounds are vastly different, yet one thing bonds them – they made history when entering their medicine degree together five years ago.

The University of Newcastle will culminate its 60th anniversary year by celebrating the first doctors to graduate from its Excellence …

Hunter Medical Research Institute (HMRI) recognised the outstanding achievements of its research community at the 2025 HMRI Awards, held at Newcastle City Hall on Friday evening.

The University of Newcastle has recognised its next generation of change-makers, from entrepreneurs tackling waste and sustainability, to passionate leaders driving community health initiatives, at this year’s Employability Excellence Awards.

The Mark Hughes Foundation Centre for Brain Cancer Research is thrilled to announce that we have now commenced an international collaboration with the Gregory lab at the Duke University Preston Robert Tisch Brain Tumor Centre, led by Professor Simon Gregory.

The Mark Hughes Foundation Centre for Brain Cancer Research is thrilled to announce that we have now commenced an international collaboration with the Gregory lab at the Duke University Preston Robert Tisch Brain Tumor Centre, led by Professor Simon Gregory.